Grace Therapeutics, Inc. (GRCE)

Financing Cash Flow

$4.04M

TTM · Period ending: · USD

GRCE logo

GRCE Financing Cash Flow

Latest reported$4.04M
GRCE TTM Cash from Financing ($4.29M → $4.04M)
High-resolution chart · PNG

GRCE financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Grace Therapeutics, Inc. Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
4,039,231
3,712,231
17,745,000
13,704,231
13,705,000
14,032,000
0
0
7,359,000
7,359,000
7,359,000
7,359,000
109,000
304,000
304,000
304,000
195,000
0
43,564,121
68,776,116
73,345,411
75,562,887
31,024,201
12,929,206
14,955,911
12,772,435
12,906,531
41,790,206
35,096,684
42,998,359
43,859,708
17,293,625
17,390,341
9,130,960
9,109,336
-327,547
-336,708
-12,941
-13,025
-11,038
-1,845
-6,351
-6,309
-7,645
39,056
21,593,474
22,099,600
22,465,614
22,438,547
1,067,700
566,384
227,895
221,085
2,329,959
9,945,361
9,955,565
9,943,121
7,834,186
4,431,490
4,395,241
4,396,155
4,293,044
76,729
77,893
77,400
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.